Cagatay M. CULCUOGLU

Massive Bio's CEO Selin Kurnaz recently made a captivating appearance on Demirören Media, featuring prominent TV channels such as CNN Türk, Kanal D, Euro D, and TEVE 2. In this exclusive interview, Selin Kurnaz shared valuable insights on the crucial role of clinical trials and the remarkable impact of AI technology in revolutionizing cancer treatment. As the forefront provider of cancer clinical trial services globally, Massive Bio continues to pave the way for innovative solutions. Please click to watch: youtu.be/IJMYlWgKr7g #MassiveBio #ClinicalTrials #AITechnology #CancerCare

🌟 We're thrilled to announce that our CEO and Co-Founder, Selin Kurnaz, will be attending ASCO 2023 - the premier event for oncology professionals to discuss the latest advancements in cancer research and treatment. 📅: June 2-6, 2023 📍: McCormick Place, Chicago, IL, USA

📣 Join us at the prestigious American Society of Clinical Oncology (ASCO) annual meeting from June 2nd to June 6th! To learn more: massivebio.com/revolutionary… #ASCO2023 #RevolutionizingCancerCare #MassiveBio

Massive Bio, the leading AI analytics company specializing in precision oncology, has been chosen by the Precision Cancer Consortium (PCC), a collaboration of renowned global biopharmaceutical companies, to revolutionize clinical trial matching using their innovative AI analytics tools. Established in 2022, PCC comprises prestigious names like AstraZeneca, Bayer, Eli Lilly & Company, GSK, Johnson & Johnson/Janssen, Novartis, and Roche, all sharing a common goal of providing comprehensive testing for cancer patients worldwide. 🌍 Through this groundbreaking partnership, Massive Bio will integrate PCC member clinical trial protocols and patient inclusion/exclusion criteria into their cutting-edge machine learning matching algorithms within the SYNERGY-AI platform. Leveraging Massive Bio's Deep Learning Clinical Trial Matching System (DLCTMS), this collaboration aims to enhance the quality and efficiency of matching patients to trials across various sponsor programs. 🤝 The result? Improved patient access to targeted Next Generation Sequencing (NGS) testing and personalized interventions. By optimizing the clinical trial matching process, this collaboration will unlock new opportunities for cancer patients and empower them with tailored treatment options. 🎯 We are thrilled to be part of this groundbreaking effort to advance precision oncology and provide hope for millions of patients. Stay tuned for more updates on this game-changing partnership! 🚀 Read more : massivebio.com/precision-can… #MassiveBio #PrecisionOncology #ClinicalTrialMatching #AIAnalytics #PrecisionCancerConsortium #Innovation #PersonalizedMedicine

@DrBonillaOnc @skurnaz @Culcuoglu

Big news N°3! 📣 @MassiveBio and @OncologyInst (TOI) team up🤝to transform cancer care and AI-enabled research. With an extensive nationwide network and AI-powered technology, they're set to revolutionize oncology data analysis💻, connecting patients to life-saving treatments and groundbreaking clinical trials. A game-changer for cancer patients everywhere. #PrecisionMedicine #AIforHealth #ASCO23 businesswire.com/news/home/2…

Introducing @skurnaz and @DrBonillaOnc, co-founders of @MassiveBio with @Culcuoglu, at the #ASCO23 Annual Meeting currently underway in Chicago. Advocating for oncologic patients' access to clinical trials using AI-powered technology. Think further, Think @MassiveBio. #AIforHealth #ClinicalTrials #DrArturoAI #Oncology

📌Last Chance! Get a reminder for "How AI is Driving Personalized Cancer Treatment" 👉: facebook.com/events/11385480… 🗓️: March 28th 2:00 pm ET RSVP to learn more about AI's new role in cancer treatment and get the chance to ask your questions during the live Q&A!

How is Mantle Cell Lymphoma (MCL) Treated? massivebio.com/page-mantle-c… There are nearly 100 active #clinicaltrials for MCL available now! Standard treatments: • Chemotherapy • Targeted therapy • Steroids • Radiation therapy • Bone Marrow Transplant and Stem Cell Transplant

Massive Bio aims to be the first to establish a footprint in #Europe among oncology patient recruitment companies: massivebio.com/massive-bio-a… The Clinical Trials Regulation was passed earlier this year to ensure the EU offers clinical research on a large scale, with high standards of public transparency and safety for clinical trial participants. #oncology #EU #massivebio #patientcare #growth #global #clinicaltrials

Check out Massive Bio’s latest blog articles on cancer types and topics such as treatments, clinical trials, symptoms, testing, diagnosis, and the latest in #cancerresearch. Read more: massivebio.com/resources/?ca… #blog #cancer #massivebio #cancerresearch #cancertrials

"Advances in AI have significantly changed the management of colorectal #cancer and other malignancies". ➡️ massivebio.com/arturo-loaiza… Read more about the 2023 @NCODAorg International Spring Forum keynote speech from Massive Bio Co-founder Dr. Arturo Loaiza-Bonilla @drbonillaonc.